Deferiprone-induced agranulocytosis: 20 years of clinical observations (Q37456259)

20 August 2017

Deferiprone-induced agranulocytosis: 20 years of clinical observations (English)

1 reference

20 August 2017

1 reference

Fernando Tricta

1

1 reference

20 August 2017

Jack Uetrecht

2

1 reference

20 August 2017

Renzo Galanello

3

1 reference

20 August 2017

John Connelly

4

1 reference

20 August 2017

Anna Rozova

5

1 reference

20 August 2017

Michael Spino

6

1 reference

20 August 2017

Jan Palmblad

7

1 reference

20 August 2017

14 July 2016

1 reference

American Journal of Hematology

20 August 2017

1 reference

20 August 2017

91

1 reference

20 August 2017

10

1 reference

20 August 2017

1026-1031

1 reference

Agranulocytosis due to deferiprone: a case report with cytomorphological and functional bone marrow examination

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129477

Deferiprone chelation therapy for thalassemia major

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129477

Prevalence, phenotype and inheritance of benign neutropenia in Arabs

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129477

Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129477

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129477

Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129477

Neutrophil counts in persons of African origin

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129477

Results of long-term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron Chelators

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129477

Fatal agranulocytosis after deferiprone therapy in a child with Diamond-Blackfan anemia.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129477

Incidence of Neutropenia during Treatment of Bone-Related Infections with Piperacillin-Tazobactam

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129477

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129477

Agranulocytosis in a patient with thalassaemia major during treatment with the oral iron chelator, 1,2-dimethyl-3-hydroxypyrid-4-one

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129477

The impact of previous or concomitant IFN therapy on deferiprone-induced agranulocytosis and neutropenia: a retrospective study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129477

The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129477

Deviating from safety guidelines during deferiprone therapy in clinical practice may not be associated with higher risk of agranulocytosis

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129477

Continuation of deferiprone therapy in patients with mild neutropenia may not lead to a more severe drop in neutrophil count

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129477

The safety, tolerability, and efficacy of a liquid formulation of deferiprone in young children with transfusional iron overload

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129477

Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5129477

Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes

2 September 2018

1 reference

12 December 2020

Recent advances in the understanding of iron metabolism and iron-related diseases

1 reference

12 December 2020

Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland

1 reference

12 December 2020

Clozapine-induced agranulocytosis in Finland, 1982-2007: long-term monitoring of patients is still warranted

1 reference

12 December 2020

Deferiprone-associated myelotoxicity

1 reference

12 December 2020

Agranulocytosis and thrombocytopenia in patient with Blackfan-Diamond anaemia during oral chelator trial

1 reference

12 December 2020

Combined therapy with deferiprone and desferrioxamine

1 reference

12 December 2020

Safety profile of the oral iron chelator deferiprone: a multicentre study

1 reference

12 December 2020

Combined oral and parenteral iron chelation in beta thalassaemia major

1 reference

12 December 2020

Identifiers

DOI

10.1002/AJH.24479

1 reference

20 August 2017

1 reference

20 August 2017

1 reference